Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

HPV type 56 can hide in hair follicles even without visible warts.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

Timely and coordinated efforts are crucial in managing a public health crisis like COVID-19.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

COVID-19 affects multiple body systems and complicates treatment; accurate testing is crucial.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Polyomavirus A2 infection in newborn mice caused hair follicle tumors.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.